{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:26:10Z","timestamp":1791321970808,"version":"4.3.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T00:00:00Z","timestamp":1387843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s12032-013-0816-0","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T09:21:59Z","timestamp":1387790519000},"source":"Crossref","is-referenced-by-count":28,"title":["A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1"],"prefix":"10.1007","volume":"31","author":[{"given":"Yichao","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanlong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harri","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauli","family":"Puolakkainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,24]]},"reference":[{"key":"816_CR1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212\u201336.","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"816_CR2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJMe1210322","volume":"367","author":"B Pasche","year":"2012","unstructured":"Pasche B. Aspirin\u2013from prevention to targeted therapy. N Engl J Med. 2012;367(17):1650\u20131.","journal-title":"N Engl J Med"},{"key":"816_CR3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","volume":"82","author":"J Folkman","year":"1990","unstructured":"Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82:4\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"816_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.ATV.0000252062.48280.61","volume":"27","author":"Y Sato","year":"2007","unstructured":"Sato Y, Sonoda H. The vasohibin family: a negative regulatory system of angiogenesis generally programmed in endothelial cells. Arterioscl Thromb Vasc Biol. 2007;27:37\u201341.","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"816_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J. Angiogenesis in cancers, vascular, rheumatoid and other disease. Nat Med. 1995;1:27\u201331.","journal-title":"Nat Med"},{"key":"816_CR6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242\u20138.","journal-title":"Nature"},{"key":"816_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/scbi.1998.0091","volume":"9","author":"T Veikkola","year":"1999","unstructured":"Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol. 1999;9:211\u201320.","journal-title":"Semin Cancer Biol"},{"key":"816_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","volume":"285","author":"DW Dawson","year":"1999","unstructured":"Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245\u20138.","journal-title":"Science"},{"key":"816_CR9","first-page":"1574","volume":"43","author":"RZ Renno","year":"2002","unstructured":"Renno RZ, Youssri AI, Michaud N, Gragoudas ES, Miller JW. Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:1574\u201380.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"816_CR10","doi-asserted-by":"crossref","first-page":"32419","DOI":"10.1074\/jbc.272.51.32419","volume":"272","author":"Y Hiraki","year":"1997","unstructured":"Hiraki Y, Inoue H, Iyama K, Kamizono A, Ochiai M, Shukunami C, et al. Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem. 1997;272:32419\u201326.","journal-title":"J Biol Chem"},{"key":"816_CR11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1476","volume":"12","author":"M Yoshioka","year":"2006","unstructured":"Yoshioka M, Yuasa S, Matsumura K, Kimura K, Shiomi T, Kimura N, et al. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med. 2006;12:1151\u20139.","journal-title":"Nat Med"},{"key":"816_CR12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/72303","volume":"6","author":"M Zhang","year":"2000","unstructured":"Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat Med. 2000;6:196\u20139.","journal-title":"Nat Med"},{"key":"816_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3816\/CBC.2002.n.032","volume":"3","author":"N Maass","year":"2002","unstructured":"Maass N, Nagasaki K, Ziebart M, Mundhenke C, Jonat W. Expression and regulation of tumor suppressor gene maspin in breast cancer. Clin Breast Cancer. 2002;3:281\u20137.","journal-title":"Clin Breast Cancer"},{"key":"816_CR14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI200421152","volume":"114","author":"K Watanabe","year":"2004","unstructured":"Watanabe K, Hasegawa Y, Yamashita H, Shimizu K, Ding Y, Abe M, et al. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest. 2004;114:898.","journal-title":"J Clin Invest"},{"key":"816_CR15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2004.12.073","volume":"327","author":"K Shimizu","year":"2005","unstructured":"Shimizu K, Watanabe K, Yamashita H, Abe M, Yoshimatsu H, Ohta H, et al. Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells. Biochem Biophys Res Commun. 2005;327:700\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"816_CR16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1096\/fj.05-5046fje","volume":"20","author":"JK Shen","year":"2006","unstructured":"Shen JK, Yang XR, Sato Y, Campochiaro PA. Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization. FASEB J. 2006;20:723\u20135.","journal-title":"FASEB J"},{"key":"816_CR17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2006.04.176","volume":"345","author":"H Yamashita","year":"2006","unstructured":"Yamashita H, Abe M, Watanabe K, Shimizu K, Moriya T, Sato A, et al. Vasohibin prevents arterial neointimal formation through angiogenesis inhibition. Biochem Biophys Res Commun. 2006;345:919\u201325.","journal-title":"Biochem Biophys Res Commun"},{"key":"816_CR18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1349-7006.2008.00777.x","volume":"99","author":"K Yoshinaga","year":"2008","unstructured":"Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, Niikura H, et al. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer. Cancer Sci. 2008;99:914.","journal-title":"Cancer Sci"},{"key":"816_CR19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1349-7006.2008.01015.x","volume":"100","author":"K Tamaki","year":"2008","unstructured":"Tamaki K, Moriya T, Sato Y, Ishida T, Maruo Y, Yoshinaga K, et al. VASH1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. Cancer Sci. 2008;100:88.","journal-title":"Cancer Sci"},{"key":"816_CR20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2353\/ajpath.2009.080788","volume":"175","author":"T Hosaka","year":"2009","unstructured":"Hosaka T, Kimura H, Heishi T, Suzuki Y, Miyashita H, Ohta H, et al. Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis. Am J Pathol. 2009;175:430\u20139.","journal-title":"Am J Pathol"},{"key":"816_CR21","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/jcp.2005.035477","volume":"59","author":"SN Wang","year":"2006","unstructured":"Wang SN, Yeh YT, Yang SF, Chai CY, Lee KT. Potential role of leptin expression in hepatocellular carcinoma. J Clin Pathol. 2006;59:930\u20134.","journal-title":"J Clin Pathol"},{"key":"816_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","volume":"324","author":"N Weidner","year":"1991","unstructured":"Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1\u20138.","journal-title":"N Engl J Med"},{"key":"816_CR23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","volume":"386","author":"W Risau","year":"1997","unstructured":"Risau W. Mechanism of angiogenesis. Nature. 1997;386:671\u20134.","journal-title":"Nature"},{"key":"816_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27\u201331.","journal-title":"Nat Med"},{"key":"816_CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353\u201364.","journal-title":"Cell"},{"key":"816_CR26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc905","volume":"2","author":"RS Kerbel","year":"2002","unstructured":"Kerbel RS, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer. 2002;2:727\u201339.","journal-title":"Nat Rev Cancer"},{"key":"816_CR27","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932\u20136.","journal-title":"Nature"},{"key":"816_CR28","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1172\/JCI29314","volume":"116","author":"HG Kopp","year":"2006","unstructured":"Kopp HG, Hooper AT, Broekman MJ, Avecilla ST, Petit I, Luo M, et al. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. J Clin Invest. 2006;116:3277\u201391.","journal-title":"J Clin Invest"},{"key":"816_CR29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/jcs.1988.Supplement_10.16","volume":"10","author":"BI Lord","year":"1988","unstructured":"Lord BI. Feedback regulators in normal and tumor tissues. J Cell Sci Suppl. 1988;10:231\u201342.","journal-title":"J Cell Sci Suppl"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0816-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0816-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0816-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T08:23:30Z","timestamp":1564993410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0816-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,24]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["816"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0816-0","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,24]]},"article-number":"816"}}